That split is now reshaping how employers write drug policy, and it has real consequences for anyone trying to access addiction treatment while holding down a job.
Why Workplace Cannabis Policy Matters For Treatment
Medical cannabis is legal in roughly 40 states and recreational use is legal in 24 states plus Washington, D.C. Federal law has not caught up.
A proposed move from Schedule I to Schedule III has not been finalized as of April 2026, according to reporting from Forbes. Until it is, cannabis remains federally illegal even where state law allows it.
That gap is forcing employers to rewrite policy in ways that affect far more than recreational users. Drug testing built on a simple pass or fail model cannot distinguish between someone using cannabis under a state medical program, someone using it recreationally off the clock, and someone whose substance use has become a problem that requires addiction treatment.
THC can stay detectable for days or weeks, so a positive test often reflects past use rather than current impairment.
Drug Testing Is Losing Its Clarity
According to the Forbes report, one testing industry executive described the mismatch directly: employers are still using binary pass or fail systems designed for an earlier era, and that gap is creating legal and insurance risk.
For someone in early recovery or currently in outpatient addiction treatment, that same ambiguity can complicate return-to-work conversations, since a test cannot show whether cannabis use is incidental, medically authorized, or a sign of a substance use disorder that needs professional support.
Industries that once relied on strict testing, including retail, hospitality, logistics, and construction, are loosening cannabis policies to compete for workers in a tight labor market.
That shift lowers one barrier to employment but does not answer a harder question for HR teams: how to support an employee who needs addiction treatment without treating cannabis policy and substance use disorder as the same issue.
Job Protection During Treatment
Workplace cannabis policy is evolving alongside a separate, longstanding protection that treatment seekers should know about.
The Family and Medical Leave Act can provide job-protected, unpaid leave for eligible employees who need time away to pursue addiction treatment, regardless of which substance is involved.
As drug policies shift and employers rewrite handbooks, that FMLA protection remains a stable option for someone who needs to step away for detox, inpatient care, or an intensive outpatient program without risking their job.
Insurance coverage is the other piece of the puzzle. Whether cannabis is eventually rescheduled or not, most private insurance plans, along with Medicaid and Medicare, are required to cover addiction treatment services under mental health parity law.
Understanding what a plan actually covers, including copays, deductibles, and network restrictions, is often the first practical step for someone weighing treatment options.
Off-Duty Protections and Safety-Sensitive Roles
A newer trend outlined in the Forbes report is the rise of state laws protecting off-duty cannabis use, so long as there is no on-the-job impairment.
These protections are not universal, and they typically carve out exceptions for safety-sensitive positions and federal contractors, where strict testing requirements remain in place regardless of state law.
Transportation and other federally regulated industries are not expected to loosen testing even if cannabis is rescheduled.
If cannabis does move to Schedule III, workplaces may eventually treat it more like a prescribed medication such as an antidepressant or sleep aid, according to Dr. Dave Rabin of The Board of Medicine, who was quoted in the Forbes report.
That would represent a meaningful shift from treating cannabis as an illicit substance to managing it within the same medical framework used for other regulated drugs.
What This Means for Treatment Seekers
For someone weighing whether to seek help for cannabis use, another substance, or a co-occurring issue, the changing legal landscape does not change the core facts.
FMLA protections exist independent of drug scheduling, insurance parity law still applies, and treatment options ranging from outpatient counseling to inpatient care remain available regardless of how an employer’s cannabis policy is written.
Workplace policy uncertainty is a reason to get clear information before making a decision, not a reason to delay care.
Exploring Treatment Options
Anyone concerned about their own cannabis use, or use of another substance, can start by understanding the treatment types available, from outpatient counseling to medically supervised levels of care.
Verifying insurance coverage before starting treatment can prevent surprises about cost. Employees weighing time off should also review their FMLA eligibility, since job protection during treatment does not depend on which substance is involved.
Rehab.com’s directory includes verified treatment centers nationwide. Call
800-985-8516
( 
Sponsored Helpline )
to speak with a treatment advisor about options that fit your situation and coverage.
